We are live on
!
Find out more
VEA
Virtus ETF Advisers Portfolio holdings
AUM
$215M
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
+12.8%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$237M
AUM Growth
-$4.18M
(-1.7%)
Cap. Flow
-$18.3M
Cap. Flow
% of AUM
-7.71%
Top 10 Holdings %
Top 10 Hldgs %
7.93%
Holding
416
New
61
Increased
247
Reduced
47
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.78M |
| 2 |
EOG Resources
EOG
|
+$1.78M |
| 3 |
ConocoPhillips
COP
|
+$1.72M |
| 4 |
Imperial Oil
IMO
|
+$1.64M |
| 5 |
Vornado Realty Trust
VNO
|
+$1.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ryman Hospitality Properties
RHP
|
+$2.57M |
| 2 |
Western Midstream Partners
WES
|
+$2.52M |
| 3 |
INN
Summit Hotel Properties
INN
|
+$2.43M |
| 4 |
Brookfield Renewable
BEPC
|
+$2.38M |
| 5 |
Grupo Aeroportuario del Pacifico
PAC
|
+$2.16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.46% |
| 2 | Real Estate | 18.03% |
| 3 | Energy | 13.68% |
| 4 | Materials | 11.34% |
| 5 | Utilities | 10.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YMAB
201
DELISTED
Y-mAbs Therapeutics
YMAB
| $363K | 0.15% |
11,993
+331
| +3% | +$13.6K |
|
|
JRO
202
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
| $361K | 0.15% |
37,860
+1,257
| +3% | +$11.6K |
|
203
BioCryst Pharmaceuticals
BCRX
$2.45B
| $359K | 0.15% |
35,331
+624
| +2% | +$6.43K |
|
204
Nuveen Floating Rate Income Fund
JFR
$1.23B
| $359K | 0.15% |
37,172
+1,262
| +4% | +$11.8K |
|
205
Quince Therapeutics
QNCX
$18M
| $359K | 0.15% |
50
+1
| +2% | +$7.2K |
|
|
LITS
206
Lite Strategy Inc
LITS
$33.5M
| $356K | 0.15% |
5,186
+91
| +2% | +$6.36K |
|
|
MRNS
207
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $355K | 0.15% |
22,912
+409
| +2% | +$5.92K |
|
208
Alaunos Therapeutics
TCRT
$4.64M
| $350K | 0.15% |
648
+12
| +2% | +$7.47K |
|
209
Immatics
IMTX
$1.15B
| $348K | 0.15% |
31,058
+550
| +2% | +$6.24K |
|
|
ITOS
210
DELISTED
iTeos Therapeutics
ITOS
| $345K | 0.15% |
10,092
+176
| +2% | +$6.36K |
|
|
DCF
211
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
| $343K | 0.14% |
36,617
+1,578
| +5% | +$14.2K |
|
212
Arvinas
ARVN
$525M
| $340K | 0.14% |
5,151
+98
| +2% | +$7.5K |
|
213
Annexon
ANNX
$819M
| $339K | 0.14% |
12,171
+213
| +2% | +$5.86K |
|
214
Celldex Therapeutics
CLDX
$2.79B
| $339K | 0.14% |
16,464
+290
| +2% | +$6.66K |
|
|
AFMD
215
DELISTED
Affimed
AFMD
| $338K | 0.14% |
4,271
+74
| +2% | +$4.8K |
|
|
EFR
216
Eaton Vance Senior Floating-Rate Fund
EFR
$312M
| $335K | 0.14% |
24,329
+3,527
| +17% | +$47.5K |
|
|
IMGN
217
DELISTED
Immunogen Inc
IMGN
| $335K | 0.14% |
41,359
+724
| +2% | +$5.91K |
|
218
Crinetics Pharmaceuticals
CRNX
$8.88B
| $334K | 0.14% |
21,882
+395
| +2% | +$6.12K |
|
219
MeiraGTx Holdings
MGTX
$1.1B
| $334K | 0.14% |
23,179
+416
| +2% | +$6.5K |
|
|
SRNE
220
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $332K | 0.14% |
40,100
+713
| +2% | +$7.53K |
|
|
PHD
221
DELISTED
Pioneer Floating Rate Fund
PHD
| $331K | 0.14% |
28,849
+4,059
| +16% | +$44.4K |
|
222
TG Therapeutics
TGTX
$8.5B
| $331K | 0.14% |
6,868
+125
| +2% | +$6.01K |
|
223
Cytokinetics
CYTK
$10.9B
| $329K | 0.14% |
14,136
+247
| +2% | +$5.27K |
|
224
Verastem
VSTM
$542M
| $327K | 0.14% |
11,025
+195
| +2% | +$5.46K |
|
|
KZR
225
DELISTED
Kezar Life Sciences
KZR
| $324K | 0.14% |
5,431
+96
| +2% | +$5.61K |
|
Similar funds
NCM
SSA
LIWM
VFG
IAM
1M
GC
RC
Virtus ETF Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, Virtus ETF Advisers held 416 positions worth $237M, down 1.7% from $241M the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Virtus ETF Advisers withdrew a net $18.3M in Q1 2021, closing 61 positions and reducing 47 holdings. Its most notable exit was Ryman Hospitality Properties, an estimated $2.57M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 30% a quarter earlier, followed by Real Estate and Energy.
Against the trend, Virtus ETF Advisers opened a new position in Pioneer Natural Resource Co. worth $1.99M.
- Virtus ETF Advisers's largest Q1 2021 buy was Pioneer Natural Resource Co.: 12,538 shares worth $1.99M.
- Virtus ETF Advisers added most to Oaktree Specialty Lending in Q1 2021, an estimated $216K increase.
- Virtus ETF Advisers's biggest Q1 2021 reduction was Avient, cutting an estimated $916K.
- Virtus ETF Advisers fully exited Ryman Hospitality Properties in Q1 2021, selling an estimated $2.57M.
- Virtus ETF Advisers's ten largest holdings make up 7.9% of its $237M portfolio in Q1 2021.
- Virtus ETF Advisers opened 61 new positions and closed 61 in Q1 2021.
- Virtus ETF Advisers's portfolio value fell 1.7% quarter-over-quarter to $237M.
Based on Virtus ETF Advisers's 13F filing for Q1 2021, filed 17 May 2021.